|
Security
|
|
Shares
|
Value
|
|
Common Stocks
|
|||
|
Aerospace & Defense — 10.4%
|
|||
|
General Dynamics Corp.
|
|
78,065
|
$ 26,793,468
|
|
Banks — 8.2%
|
|||
|
JPMorgan Chase & Co.
|
|
72,443
|
21,309,833
|
|
Consumer Finance — 7.2%
|
|||
|
American Express Co.
|
|
61,141
|
18,493,930
|
|
Consumer Staples Distribution & Retail — 4.0%
|
|||
|
Walmart, Inc.
|
|
82,272
|
10,224,764
|
|
Electronic Equipment, Instruments & Components — 1.6%
|
|||
|
Keysight Technologies, Inc.(a)
|
|
14,874
|
4,199,971
|
|
Energy Equipment & Services — 1.4%
|
|||
|
SLB Ltd.
|
|
70,328
|
3,614,156
|
|
Financial Services — 14.9%
|
|||
|
Berkshire Hathaway, Inc., Class B(a)
|
|
55,371
|
26,533,783
|
|
Visa, Inc., Class A
|
|
39,748
|
12,013,436
|
|
|
|
|
38,547,219
|
|
Health Care Equipment & Supplies — 0.4%
|
|||
|
Alcon AG
|
|
13,736
|
1,035,008
|
|
Household Products — 1.1%
|
|||
|
Procter & Gamble Co. (The)
|
|
20,126
|
2,906,999
|
|
Machinery — 0.0%
|
|||
|
Westinghouse Air Brake Technologies Corp.
|
|
380
|
94,966
|
|
Oil, Gas & Consumable Fuels — 4.2%
|
|||
|
BP PLC, ADR
|
|
31,546
|
1,482,662
|
|
Exxon Mobil Corp.
|
|
54,584
|
9,260,721
|
|
|
|
|
10,743,383
|
|
Pharmaceuticals — 18.7%
|
|||
|
AstraZeneca PLC
|
|
64,000
|
12,622,080
|
|
Security
|
|
Shares
|
Value
|
|
Pharmaceuticals (continued)
|
|||
|
Johnson & Johnson
|
|
55,418
|
$ 13,546,376
|
|
Merck & Co., Inc.
|
|
68,117
|
8,193,794
|
|
Novartis AG, ADR
|
|
68,681
|
10,491,023
|
|
Organon & Co.
|
|
6,811
|
40,798
|
|
Pfizer, Inc.
|
|
76,397
|
2,145,228
|
|
Sandoz Group AG, ADR
|
|
13,736
|
1,074,155
|
|
Viatris, Inc.
|
|
14,108
|
190,599
|
|
|
|
|
48,304,053
|
|
Software — 22.6%
|
|||
|
Microsoft Corp.
|
|
157,368
|
58,252,913
|
|
Tobacco — 5.2%
|
|||
|
Altria Group, Inc.
|
|
77,000
|
5,081,230
|
|
Philip Morris International, Inc.
|
|
50,136
|
8,289,486
|
|
|
|
|
13,370,716
|
|
Total Long-Term Investments — 99.9%
(Cost: $14,024,299)
|
257,891,379
|
||
|
Short-Term Securities
|
|||
|
Money Market Funds — 0.2%
|
|||
|
BlackRock Liquidity Funds, T-Fund, Institutional Shares,
3.55%(b)(c)
|
|
425,637
|
425,637
|
|
Total Short-Term Securities — 0.2%
(Cost: $425,637)
|
425,637
|
||
|
Total Investments — 100.1%
(Cost: $14,449,936)
|
258,317,016
|
||
|
Liabilities in Excess of Other Assets — (0.1)%
|
(163,454
)
|
||
|
Net Assets — 100.0%
|
$ 258,153,562
|
||
|
(a)
|
Non-income producing security.
|
|
(b)
|
Affiliate of the Fund.
|
|
(c)
|
Annualized 7-day yield as of period end.
|
|
Affiliated Issuer
|
Value at
12/31/25
|
Purchases
at Cost
|
Proceeds
from Sales
|
Net
Realized
Gain
(Loss)
|
Change in
Unrealized
Appreciation
(Depreciation)
|
Value at
03/31/26
|
Shares
Held at
03/31/26
|
Income
|
Capital
Gain
Distributions
from
Underlying
Funds
|
|
BlackRock Cash Funds: Institutional, SL Agency
Shares(a)
|
$ —
|
$ —
|
$ —
|
$ —
|
$ —
|
$ —
|
—
|
$ 58
(b)
|
$ —
|
|
BlackRock Liquidity Funds, T-Fund, Institutional
Shares
|
570,604
|
—
|
(144,967
)(c)
|
—
|
—
|
425,637
|
425,637
|
4,583
|
—
|
|
|
|
|
|
$ —
|
$ —
|
$ 425,637
|
|
$ 4,641
|
$ —
|
|
(a)
|
As of period end, the entity is no longer held.
|
|
(b)
|
All or a portion represents securities lending income earned from the reinvestment
of cash collateral from loaned securities, net of collateral investment fees, and
other payments to and
from borrowers of securities.
|
|
(c)
|
Represents net amount purchased (sold).
|
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|
Assets
|
|
|
|
|
|
Investments
|
|
|
|
|
|
Long-Term Investments
|
|
|
|
|
|
Common Stocks
|
$ 257,891,379
|
$ —
|
$ —
|
$ 257,891,379
|
|
Short-Term Securities
|
|
|
|
|
|
Money Market Funds
|
425,637
|
—
|
—
|
425,637
|
|
|
$ 258,317,016
|
$ —
|
$ —
|
$ 258,317,016
|
|
Portfolio Abbreviation
|
|
|
ADR
|
American Depositary Receipt
|